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Summary
 
Disease severity in 
 
Plasmodium falciparum
 
 infections is a direct consequence of the parasite’s efficient
evasion of the defense mechanisms of the human host. To date, one parasite-derived molecule, the
antigenically
 
 
 
variant adhesin 
 
P. falciparum
 
 erythrocyte membrane protein 1 (PfEMP1), is known to
be transported to the infected erythrocyte (pRBC) surface, where it mediates binding to different
host receptors. Here we report that multiple additional proteins are expressed by the parasite at the
pRBC surface, including a large cluster of clonally variant antigens of 30–45 kD. We have found
these antigens to be identical to the rifins, predicted polypeptides encoded by the 
 
rif
 
 multigene
family. These parasite products, formerly called rosettins after their identification in rosetting para-
sites, are prominently expressed by fresh isolates of 
 
P
 
.
 
 falciparum
 
. Rifins are immunogenic in natural
infections and strain-specifically recognized by human immune sera in immunoprecipitation
of surface-labeled pRBC extracts. Furthermore, human immune sera agglutinate pRBCs digested
with trypsin at conditions such that radioiodinated PfEMP1 polypeptides are not detected but rifins
are detected, suggesting the presence of epitopes in rifins targeted by agglutinating antibodies.
When analyzed by two-dimensional electrophoresis, the rifins resolved into several isoforms in the
pI range of 5.5–6.5, indicating molecular microheterogeneity, an additional potential novel source
of antigenic diversity in 
 
P
 
.
 
 falciparum
 
. Prominent polypeptides of 20, 22, 76–80, 140, and 170 kD
were also detected on the surfaces of pRBCs bearing in vitro–propagated or field-isolated parasites.
In this report, we describe the rifins, the second family of clonally variant antigens known to be
displayed by 
 
P
 
.
 
 falciparum
 
 on the surface of the infected erythrocyte.
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T
 
he morbidity and mortality associated with 
 
Plasmodium
falciparum
 
 malaria infections occurs exclusively during
the erythrocytic phase of the parasite life cycle. Strategies
used by 
 
P
 
.
 
 falciparum
 
 for maximizing survival and prolifera-
tive capacity in the bloodstream include the receptor-medi-
 
ated sequestration of 
 
P. falciparum–
 
infected erythrocytes
(pRBCs) on the vascular endothelium and the constant vari-
ation of antigenic epitopes on the pRBC surface to evade
antiparasite mechanisms of protection in the human host (1).
A polypeptide exported by the parasite to the outer face
 
of the pRBC membrane, the 200–400-kD 
 
P
 
.
 
 falciparum
 
erythrocyte membrane protein 1 (PfEMP1),
 
1
 
 is a cytoadher-
ence ligand and undergoes clonal switching (2, 3). PfEMP1
polypeptides are encoded by the 
 
var
 
 gene family (4), and
they are expressed on the infected cell surface as the para-
site develops from the ring-shaped early forms into the pig-
mented trophozoite stage, simultaneous with the onset of
adhesive capacity and antigenicity of the pRBC (5).
Studies of humoral immune responses in natural infec-
tions of 
 
P
 
. 
 
falciparum
 
 highlight the extreme diversity of anti-
genic determinants on the infected erythrocytes (6–8). Al-
though sera from individuals with a history of exposure to
the disease may contain antibodies that react with epitopes
shared by many parasite isolates, the bulk of the natural or
experimentally induced immune response to surface deter-
minants on the pRBC is strain/clone specific (9, 10). The
variant antigen PfEMP1 has been postulated to be the sole
target for specific antibodies that agglutinate pRBCs and
confer protection against clinical disease (11, 12).
 
1
 
Abbreviations used in this paper:
 
 CHO, chinese hamster ovary; HUVECs,
human umbilical vein endothelial cells; PECAM1, platelet/endothelial
cell adhesion molecule 1; PfEMP1, 
 
P
 
.
 
 falciparum
 
 erythrocyte membrane
protein 1. 
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To date, PfEMP1 is the only molecularly characterized
protein of 
 
P
 
.
 
 falciparum
 
 shown to be located on the surface
of the infected erythrocyte (2). PfEMP1 mediates binding
to vascular endothelial receptors such as CD36, intercellular
adhesion molecule 1, and thrombospondin (13), as well as to
uninfected erythrocytes in the adhesion phenomenon known
as rosetting (14, 15). Polypeptides of low molecular mass
have been radiolabeled on the pRBC surface and termed
rosettins after their identification in rosetting strains (16).
Based on this and additional observations suggesting that
the parasite exports more than one set of polypeptides to
the host cell surface (reference 17 and our unpublished data),
we set out to systematically reanalyze the surfaces of pRBCs
harboring 
 
P
 
.
 
 falciparum
 
 recently isolated from malaria pa-
tients or strains and clones adapted to laboratory culture con-
ditions. Here, we have focused the analysis and characteriza-
tion to parasite-derived products with a molecular size 
 
,
 
200
kD, a size distinct from the known PfEMP1 antigens.
 
Materials and Methods
 
Parasites and Sera.
 
The 
 
P
 
.
 
 falciparum
 
 lines FCR3S/b (K
 
2
 
) and
FCR3S1/b (K
 
2
 
) were selected from parasites FCR3S (K
 
2
 
) and
FCR3S1 (K
 
2
 
), respectively, for cytoadherence to the CD36
receptor on C32 melanoma cells. FCR3S/a (K
 
2
 
) was obtained
from FCR3S by repeated selection for nonrosetting parasites
as described elsewhere (18). FCR3S1 was cloned by limiting
dilution from FCR3S, which originated from the FCR3 strain
isolated in The Gambia, West Africa. The subclones FCR3S1.2
(K
 
2
 
) and FCR3S1.6 (K
 
2
 
) were obtained by micromanipulation from
FCR3S1. Clones TM284S2 (K
 
1
 
), TM284S3 (K
 
1
 
), TM284S11
(K
 
1
 
), TM284S12 (K
 
1
 
), TM284S20 (K
 
1
 
), TM284S7 (K
 
2
 
),
TM284S9 (K
 
2
 
), and TM284S19 (K
 
2
 
) were derived by micro-
manipulation from the strain TM284 (K
 
1
 
), which, along with
strain TM180 (K
 
2
 
), were isolated from malaria patients in Thai-
land. The F32 strain was isolated in Tanzania. The parasite 3D7
was obtained by limiting dilution cloning of the isolate NF54,
which was derived from a patient who acquired malaria in the
airport area in Amsterdam, The Netherlands. R29 (K
 
1
 
) was
cloned from ITOR, a parasite from the ITO strain selected for
the rosetting phenotype. The parasite Dd2 was originally cloned
from the W2-MEF line of the Indochina III isolate. The 
 
P
 
.
 
 falci-
parum
 
 isolates 186, 199, 341, 347, 352, and 354 were part of a
larger panel of field parasites collected from African children in-
fected with malaria. Upon collection, the blood samples were
immediately frozen according to standard techniques. For their
analysis, the frozen blood samples were thawed and maintained in
culture in their own blood for 24–30 h until parasites developed
into the mature trophozoite stage, at which time they were har-
vested and further processed.
Sera were collected from (a) adults living in Yekepa, Liberia,
an area characterized by high perennial malaria transmission (de-
noted 022, 102, 119, 142, 163, 164, 169, 174, 179, 198, 241, and
368), (b) adults from Fajara, The Gambia, a region with seasonal
malaria transmission (denoted 072, 100, and 136), and (c) chil-
dren 1–15 yr old living in Saradidi, an area in western Kenya ho-
loendemic for malaria (denoted 011, 039, 080, 118, and 209). All
donors had had repeated malaria attacks; none had symptoms of
clinical malaria at the time of sampling. In all cases, informed
consent was obtained from the patients and/or their parents. The
sera were stored at 
 
2
 
70
 
8
 
C and heat inactivated at 56
 
8
 
C before
 
the assays. Control sera were obtained from healthy Swedish blood
donors.
 
Culture of Parasites.
 
All of the laboratory-adapted parasites
used in this study were cultured in human group O Rh
 
1
 
 erythro-
cytes at 5% hematocrit with 10% AB
 
1
 
 serum added to the malaria
culture medium containing RPMI 1640, 25 mM Hepes, 25 mM
sodium bicarbonate, and 50 mg/ml gentamycin, pH 7.4. In some
cases, cultured parasites were enriched for the rosetting pheno-
type (R
 
1
 
) as previously described (18).
 
Surface Analysis of pRBCs.
 
Surface iodination of pRBCs was
performed by the lactoperoxidase/Na
 
125
 
I/H
 
2
 
O
 
2
 
 method under
conditions of minimal intracellular labeling. In brief, 2 
 
3
 
 10
 
9
 
 cells
of a culture at 7–15% parasitemia with a majority of parasites in the
trophozoite stage were gently washed in PBS and resuspended to
1 ml in PBS plus 1 mM KI. 1 mCi of Na
 
125
 
I (Amersham) and
100 
 
m
 
l of 2 mg/ml lactoperoxidase (Sigma Chemical Co.) was
added, and the reaction was initiated by the addition of 25 
 
m
 
l of
0.03% H
 
2
 
O
 
2
 
. Four subsequent additions of 25 
 
m
 
l of 0.03% H
 
2
 
O
 
2
 
were administered at 1-min intervals. Radioiodinated cells were
washed four times with ice-cold PBS containing 5 mM KI and
resuspended in 1 ml of RPMI 1640 plus 5% sorbitol. Labeling of
intracellular hemoglobin accounted for 
 
,
 
2% of total acid-precip-
itable incorporated radiolabel. To disrupt rosettes/agglutinates,
100 IU/ml of heparin (Løvens) was added to the cell suspension,
and this was passed five times through a 23-gauge (0.6 mm inter-
nal diameter) needle using a 1-ml syringe. The cell suspension
was overlaid on top of a four-step (40, 60, 70, and 80%) Percoll
gradient in RPMI/5% sorbitol and centrifuged in a JA 20 rotor
(Beckman Instruments, Inc.) at 10,000 rpm for 30 min at room
temperature. Cells floating between the 40 and 60% Percoll layers
(
 
.
 
95% mature parasite–containing erythrocytes) were recovered
and gently washed with PBS. Enriched pRBCs were first ex-
tracted with 1% Triton X-100/PBS containing a cocktail of pro-
tease inhibitors (1 mM EDTA-N
 
2
 
, 20 
 
m
 
g/ml leupeptin, 0.7 
 
m
 
g/
ml pepstatin, 0.2 mM PMSF, and 50 
 
m
 
g/ml aprotinin) and subse-
quently extracted in a solution of 2% SDS and protease inhibitors
in PBS. The polypeptides in the Triton-insoluble fraction were
solubilized in 2% SDS-PAGE sample buffer and separated by a
gradient of 5–8.5 or 7.5–17.5% SDS-PAGE. The dried gels were
scanned and analyzed using a PhosphorImager and ImageQuant
analysis software (Molecular Dynamics).
 
Immunoprecipitation.
 
SDS or Triton X-100 extracts of surface-
radioiodinated pRBCs (25 
 
m
 
l) were mixed with 375 
 
m
 
l of NETT
(50 mM Tris, pH 7.4, 150 mM NaCl, 5 mM disodium EDTA,
20 
 
m
 
g/ml leupeptin, 50 
 
m
 
g/ml aprotinin, 0.02% sodium azide,
and 0.5% Triton X-100) buffer/10 mg/ml IgG-free BSA (Sigma
Chemical Co.) and 100 
 
m
 
l of 10% Triton X-100/PBS. 15 
 
m
 
l of se-
rum was added to 500 
 
m
 
l of reconstituted extract, and the samples
were incubated for 12 h at 4
 
8
 
C with rotation. Protein A–Sepharose
(100 
 
m
 
l of a 50% suspension in NETT buffer/10 mg/ml IgG-free
BSA) was added, and the samples were further incubated for 1 h
at room temperature with rotation. The adsorbent was then washed
twice with 1 ml of NETT, twice with 1 ml of NETT/0.35 M
NaCl, and twice with 1 ml of NETT. The Sepharose beads were
boiled for 4 min in the presence of 5% SDS-PAGE sample buffer,
and the solubilized polypeptides were separated and analyzed as
described above.
 
Trypsin Treatment of the PRBC Surface.
 
Intact or radiolabeled
pRBCs purified on Percoll gradients were digested with trypsin
(Sigma Chemical Co.) at the indicated concentrations (see Fig. 5
and Table I) for 10 min at 37
 
8
 
C. The reaction was terminated by
the addition of 1 ml soybean of trypsin inhibitor (Sigma Chemical
Co.) at 1 mg/ml in RPMI 1640/10% AB
 
1
 
 serum. Cells were 
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washed with PBS and either resuspended in RPMI–Hepes/10%
AB
 
1
 
 serum for binding and agglutination assays or extracted with
Triton X-100/SDS and analyzed by SDS-PAGE as described above.
 
Assay of Serum-induced Agglutination of pRBCs.
 
Agglutination of
parasitized red blood cells was assayed as previously described (19)
with some modifications. pRBCs cultured to trophozoite and late
schizont stages were washed three times in malaria culture me-
dium and then resuspended at 20% hematocrit. Aliquots of 25 
 
m
 
l
were mixed with an equal volume of prediluted or nonprediluted
serum to a final dilution of 1:2, 1:5, or 1:10. The pRBC–serum
mixture was incubated at 37
 
8
 
C for 1 h under a constant rotation
of 3 rpm. A 10-
 
m
 
l aliquot was mixed with 5 
 
m
 
l of acridine orange
and mounted on a glass slide, and 50 consecutive fields of vision
were examined diagonally using a 40
 
3
 
 lens in an incident UV
light microscope. Control sera from healthy Swedish blood donors
were used. Semiquantitative scoring was used for analysis. The
agglutination assay was scored negative when no agglutinates of
4 pRBCs were detected; 11, 1–5 agglutinates of 4–10 pRBCs;
21, .5 agglutinates of 4–10 pRBCs or 1–5 agglutinates of 11–20
pRBCs; 31, .5 agglutinates of 11–20 pRBCs or 1–5 aggluti-
nates of .20 pRBCs; 41, .5 agglutinates of .20 pRBCs.
Rosetting, Autoagglutination, and Cytoadherence. Rosetting of un-
infected red cells and autoagglutination of parasitized erythrocytes
was assessed by direct staining of cultures with acridine orange
(Sigma Chemical Co.) and examination using an epifluorescence
microscope. Rosetting rates were measured as previously described
(20). Spontaneous autoagglutination of pRBCs in the P. falci-
parum cultures was measured as described elsewhere (18). Adher-
ence of pRBCs to unfixed C32 melanoma cells, human umbilical
vein endothelial cells (HUVECs), chinese hamster ovary (CHO)
cells transfected with CD36 or intercellular adhesion molecule 1,
or L cells transfected with platelet/endothelial cell adhesion mol-
ecule (PECAM)1/CD31 was performed as described (21). In some
cytoadherence assays on HUVECs, C32, and L cells, rosettes
were first disrupted by adding 100 IU/ml of heparin (Løvens) to
the culture and passage (five times) through a 23-gauge (0.6 mm
internal diameter) needle using a 1-ml syringe. The cell suspen-
sion was overlaid on a four-step (40, 60, 70, and 80%) Percoll
gradient, and the trophozoite-bearing red cells were selected as
described above, washed twice in RPMI, and used for the assays
in serum-free medium.
Surface Immunofluorescence. The assay of the binding of human
nonimmune normal Swedish serum Igs to pRBCs was performed
by direct labeling of the cells using FITC-conjugated sheep anti–
human Ig antibodies (State Bacteriology Laboratory, Sweden) as
described elsewhere (22).
Results
Novel Variable Polypeptides Identified on the pRBC Surface.
Frozen blood samples from P. falciparum malaria patients
were thawed, and the cells were maintained in culture for
30 h. The intact cells were mildly radioiodinated under con-
ditions ensuring .98% isotope incorporation to surface-
exposed molecular moieties, and the labeled polypeptides
were analyzed by protein gel electrophoresis. In all six iso-
lates that developed into the mature stages, we found, in
addition to PfEMP1 bands (.200 kD), several polypeptides
with an estimated molecular mass between 33 and 39 kD
that were readily labeled on the surfaces of erythrocytes
containing parasites at the trophozoite/schizont stages, but
not on the ring-infected or uninfected RBCs from the
same blood sample (Fig. 1). The number, size, and degree
of radiolabel incorporation of these polypeptides was vari-
able and essentially unique for each isolate. Typically, the
largest of these bands (39 kD) comigrated with the heavily
radioiodinated monomer chains of erythrocytic glycophorin A
and was therefore often indistinguishable from the host pro-
tein. One to three additional labeled polypeptides 33–37 kD
in size formed a characteristic cluster of bands with isolate-
specific patterns. We then proceeded to study the pRBC
surfaces of 17 strains, lines, and clones of P. falciparum and
found that radioiodinatable polypeptides in the range of
30–45 kD were commonly exported and surface expressed
by a majority of these in vitro–propagated parasites (Fig. 2,
A–C). The number of bands and their relative radiolabel
intensities was specific for each parasite. As determined by
radioiodination experiments with highly synchronized cul-
tures, the expression of the 30–45-kD polypeptide cluster
on the pRBC surface occurred from 16 to 18 h after inva-
sion until the end of the erythrocytic cycle (data not shown),
matching the time course of expression of antigenic and
adhesive phenotypes and the onset of PfEMP1 on the pRBC
surface. These polypeptides were partially solubilized in
Triton X-100, in contrast to the extreme insolubility of
PfEMP1 in nonionic detergents. Additional parasite-specific
radiolabeled bands were detected on pRBCs infected with
some of the patient isolates or laboratory-cultured parasites
(Fig. 1 and Fig. 2, A–C). A 20-kD band was observed in
isolate 199, whereas a polypeptide of 22 kD was radiolabeled
in isolate 347 and the strain Dd2. Faint bands of 76–80 kD
were visible in several of the in vitro–propagated parasites,
and a polypeptide of 140 kD was detected in TM180, a strain
also expressing several smaller (33–39 kD) polypeptides. Most
Figure 1. Novel variable antigens expressed on the surfaces of erythro-
cytes harboring clinical isolates of P . falciparum. Frozen blood samples
from malaria patients were thawed, maintained in culture until the devel-
opment of trophozoite stages, and subsequently surface-radioiodinated as
explained in Materials and Methods. Labeled erythrocytes bearing tropho-
zoite and schizont stages were separated from ring-infected and nonin-
fected cells (RBC) in Percoll/sorbitol gradients and detergent extracted,
and the polypeptides were fractionated by SDS-PAGE. Molecular sizes
are indicated (kD). Extracts from autologous RBCs were always run in
adjoining lanes for identification of parasite-derived polypeptides, which
are indicated by asterisks (,45 kD) or closed arrowheads (100–200 kD).
PfEMP1 polypeptides are not indicated.1396 P. falciparum Exports Multiple Antigens to the Host Cell Surface
prominent was the strongly radioiodinated band of 170 kD
found in two of the clinical isolates (199 and 341) and
strain F32, as well as strain TM284 and several of its clones
(only TM284S2 is shown). None of these polypeptides
were detected on pRBCs bearing trophozoite/schizont stages
when the erythrocytes were surface 125I-labeled before par-
asite invasion (data not shown).
The 30–45-kD Surface Antigens Are Clonally Variant but
Stably Expressed In Vitro. Upon examination of the panel of
clones derived by micromanipulation from the TM284 strain
(Fig. 2 C), we observed that all five rosetting (R1) clones
(TM284S2, S3, S11, S12, and S20) had an identical pattern
of surface radiolabeled polypeptides with bands detected at
39, 80 (faint), and 170 kD and a PfEMP1 polypeptide of
340 kD (TM284S2 is shown; gels optimized for PfEMP1
separation are not shown). In contrast, each of the three
nonrosetting (R2) clones obtained (TM284S7, S9, and S19)
showed unique combinations of bands in the range of
33–45 kD and no detectable PfEMP1 proteins in the gels.
This result was consistent with the reported role of PfEMP1
as a rosetting ligand (14, 15). Moreover, the data strongly sug-
gested that the variation observed in the small surface antigens
clustered in the range of 30–45 kD had its origin in a set of
clonally variant genes. By comparing the patterns of surface-
radiolabeled polypeptides expressed by the sibling parasites
FCR3S1.2 (R1) and FCR3S1.6 (R2), sharing an isogenic
background after their cloning by micromanipulation from
the previously cloned FCR3S1 (R1), it was confirmed that
the expression of the small surface antigens (31–39 kD) of this
parasite is subjected to clonal genetic switching (Fig. 2 B).
To investigate the stability of expression of the small sur-
face antigens in parasite populations that were or were not
exposed to selective pressures other than those inherent to
in vitro growth, we 125I-labeled pRBCs periodically col-
lected from year-long continuous cultures of FCR3S1,
maintained with regular enrichment for the rosetting pheno-
type, and the Dd2 strain, cultured without selection but dis-
playing rosetting rates consistently .65%. The results showed
no change in the type of radioiodinated polypeptides of
these two parasites grown during at least 150 generations,
as assessed in at least 10 separate experiments of surface la-
beling of pRBCs (data not shown). Although similar stabil-
ity in the small surface antigen types is a characteristic of
other parasite strains undergoing long-term culture, a de-
crease in the expression of these radiolabeled bands has
been sporadically observed in some cultures.
Molecular Heterogeneity of the Small Surface Polypeptides.
We noticed that some radiolabeled bands in the 30–45-kD
cluster appeared characteristically dispersed (Fig. 2 B). This
observation prompted us to investigate possible molecular
heterogeneity not discerned in regular SDS-PAGE gels. A
two-dimensional electrophoresis analysis of an SDS extract
of FCR3S1.2 pRBCs (the one-dimensional SDS-PAGE
pattern of this parasite is shown in Fig. 2 B) revealed the
existence of charge and size microheterogeneity in the sur-
face-radioiodinated polypeptides (Fig. 3, A and B). The
parasite-specific bands of 35 and 36 kD resolved into sev-
eral molecular species or isoforms in the pI range of 5.5–6.5,
displaying a charge composition distinct from the major
proteins of the human erythrocyte surface, including the
Figure 2. Surface antigens on erythrocytes infected with parasites adapted to in vitro growth. (A) Cultures of P. falciparum strains and (B) parasite lines and
clones derived from FCR3S or (C) from the TM284 strain were processed as described for Fig. 1. The adherence of pRBCs to uninfected erythrocytes
(Rosetting), other pRBCs (Autoagglutination), or CHO cells transfected with the CD36 receptor was assessed as described elsewhere (18). Adhesion to
PECAM1/CD31 was performed as described (39). Panels of R1 and R2 clones were obtained from the TM284 strain by micromanipulation-assisted collec-
tion of trophozoite-bearing pRBC involved or not in rosettes. The parasite TM284S2 is one out of five clones displaying identical adhesive and surface-
labeled polypeptide phenotypes. The parasite-derived polypeptides are indicated as in Fig. 1, with open arrowheads indicating bands of 45–100 kD.1397 Fernandez et al.
heavily glycosylated anion transporter Band 3 and the sia-
loglycoproteins, glycophorins A and B. Polyclonal sera to
total erythrocytic antigens and mAbs to Band 3 and glyco-
phorins A, B, and C were used in immunoprecipitation
and Western blot for the identification of the normal RBC
proteins undergoing radioiodination (results not shown).
None of these antibodies recognized the parasite-specific
surface-radioiodinatable antigens of FCR3S1.2 or any other
strain/clone tested.
Small Surface Antigens in the 30–45-kD Cluster Are Identical
to Predicted Proteins Encoded by the rif Family of P. falciparum
Genes. As part of the P. falciparum genome sequencing
project, a number of intact transcriptional units sharing ho-
mology with the sequence originally called RIF (repetitive
interspersed family; reference 23) were identified in the
subtelomeric regions of chromosome 2 (24). This large
family of rif genes encoded potential transmembrane pro-
teins of 30–40 kD termed rifins. We proceeded to investi-
gate whether the variable 30–45-kD surface antigens char-
acterized here were identical to predicted rif gene products.
Rabbit antisera raised against the highly conserved 39 end of
the deduced amino acid sequence of rif genes PFB1040w,
PFB1035w, PFB0040c, and PFB0955w were used to immu-
noprecipitate SDS extracts of surface- or metabolically la-
beled pRBCs of the FCR3S1.2 clone. Antibodies in three
of the tested sera specifically recognized the small surface
polypeptides of this parasite, in particular anti-rif PFB1035w,
which immunoprecipitated bands of 35, 36 (doublet), and,
faintly, 39 kD (Fig. 4). The results proved that the small
variant antigens expressed on the pRBC surface are prod-
ucts of the rif loci.
Surface-expressed Rifins, Rosetting, and Other Binding Pheno-
types. We next investigated whether the expression of rifin
proteins on the pRBC surface was associated with rosetting
binding to uninfected erythrocytes. For this purpose, we
analyzed surface radiolabeled pRBCs in R1 and R2 para-
sites cloned by limiting dilution and subcloned by micro-
manipulation. The rosetting clone FCR3S1, derived from
the strain FCR3S by limiting dilution, consistently showed
a radioiodinated polypeptide of 35 kD. The highly rosetting,
autoagglutinating, and cytoadherent subclone FCR3S1.2,
obtained from FCR3S1 by micromanipulation, expressed
radiolabeled bands of 31, 35, and 36 kD. In contrast, the
nonrosetting, noncytoadherent sibling subclone FCR3S1.6
only exhibited the 39-kD band, a polypeptide always found
on pRBCs infected with parasites of the FCR3S lineage
(Fig. 2 B). These preliminary results were suggestive of an
association between the rosetting capacity of the parasite
and the expression of particular rifin variants on the host
cell surface. Such an association was not observed when a
similar clonal analysis was performed in another P. falci-
parum strain. Parasite clones with phenotype R1 derived
from the rosetting strain TM284 (only TM284S2 is shown
here) did not display radioiodinatable polypeptides of low
molecular mass other than the 39 kD polypeptide, whereas
nonrosetting clones (TM284S7, TM284S9, and TM284S19)
showed multiple radioiodinated polypeptides in the range
of 33–45 kD (Fig. 2 C). However, polypeptides outside the
cluster of small variant antigens were associated with rosetting
binding in TM284 parasites. A prominent surface-labeled
band corresponding to a polypeptide of 170 kD and an ad-
ditional 82-kD polypeptide were detected in TM284 and
all of its R1 clones but were not or were very faintly de-
tected in R2 clones (Fig. 2 C). In FCR3S and TM284 par-
asites, changes in binding phenotype always concurred with
changes in the expression of PfEMP1 polypeptides (data
not shown).
Controlled proteolytic digestion of intact radioiodinated
pRBCs was used to further explore possible associations
between the expression of surface antigens and binding
phenotypes. Upon incubation of surface-radioiodinated,
trophozoite-infected erythrocytes with trypsin, complete
deletion of the 35-kD rifin band of FCR3S1 occurred at
concentrations of the protease of 100 mg/ml or higher
(Fig. 5). The 39-kD polypeptide of this parasite showed a
reduced sensitivity to the protease. In comparison, the
Figure 3. Small antigens in the 30–45-kD cluster exhibit charge and
size microheterogeneity. (A) FCR3S1.2 parasite cultures were surface ra-
dioiodinated, and the trophozoite-infected pRBCs were separated and
processed as described in Materials and Methods. The isoelectric focusing
of the Triton X-100/urea–reconstituted SDS extracts was carried out as
described elsewhere (42). The focused polypeptides were size fractionated
by SDS-PAGE in a 7.5–17.5% gradient gel and detected by Phosphor-
Imagery. (B) Detail of the FCR3S1.2 clone–specific surface antigens. A
set of pI markers (Bio-Rad Labs.) was used for the determination of the
pH gradient after isoelectric focusing.1398 P. falciparum Exports Multiple Antigens to the Host Cell Surface
285-kD PfEMP1 polypeptide expressed by FCR3S1 was
cleaved at concentrations of trypsin ,1 mg/ml, in agree-
ment with our and others’ data on the high trypsin sensitiv-
ity of most PfEMP1 polypeptides. The proteolytic treatment
left the bulk of Triton X-100– and SDS-soluble polypep-
tides unaltered, with the exception of the glycophorins.
The sensitivity of the rosetting phenotype to trypsin diges-
tion of intact pRBCs closely matched that of the PfEMP1
protein, but not the removal of the 35- or 39-kD rifins
from the pRBC surface. Similarly, the trypsin sensitivity of
other adhesive phenotypes of erythrocytes bearing FCR3S1
or its clone FCR3S1.2, such as autoagglutination of in-
fected RBCs, binding to the blood group A trisaccharide,
adherence to the CD36 receptor, and binding of normal
human Igs paralleled the cleavage of PfEMP1 (data not
shown). In contrast, an association was found between the
deletion of the 35-kD rifin polypeptide and the abrogation
of pRBC binding to PECAM1/CD31, expressed constitu-
tively on HUVECs or L cells transfected with the correspond-
ing gene (Fig. 5).
The lack of association between the expression of non-
PfEMP1 antigens on the pRBC surface and adherent phe-
notypes of the parasite, with the exception of binding to
PECAM1/CD31, was further evidenced when we panned
the rosetting FCR3S and FCR3S1 parasites on C32 mela-
noma cells expressing the CD36 receptor. The resulting
highly CD36-cytoadherent, nonrosetting parasite lines ex-
pressed different patterns of surface-radioiodinatable polypep-
tides, 36 and 39 kD in FCR3S/b and 39 kD in FCR3S1/b.
Polypeptides of 39 kD were also detected in noncytoadher-
ent, nonrosetting parasites (Fig. 2 B).
Immune Recognition of Variant Rifin Antigens. To assess the
natural antigenicity of rifin polypeptides, we initially tested
two human hyperimmune sera in immunoprecipitation of
SDS extracts of surface 125I-labeled pRBCs of the FCR3S1.2
clone. Antibodies in these two sera recognized radioiodinated
rifins of 35, 36 (doublet), and 39 kD in addition to PfEMP1
(Fig. 6 A). Rabbit antisera raised against GST fusion pro-
teins comprising the semiconserved DBL1 and the highly
conserved ATS domains of the var/PfEMP1 expressed by
FCR3S1.2 immunoprecipitated PfEMP1 polypeptides but
did not react with rif gene products. Having obtained the
first evidence that rifin polypeptides were naturally immu-
nogenic, we next carried out an expanded analysis of the
antigenicity of these parasite products in natural infections.
For this purpose, we used a panel of 18 sera from malaria-
Figure 4. Recognition of the small surface antigens
in the 30–45-kD cluster by antibodies to rif gene–pre-
dicted peptides. (A) Immunoprecipitation of [125I]Na
surface-labeled SDS extracts of FCR3S1.2 pRBCs with
either human immune sera (no. 179) or rabbit antisera
raised to the 39 conserved end domain of the indicated
rif genes mapping to chromosome 2 of P. falciparum
strain 3D7 (24). (B) Immunoprecipitation of [35S]cys-
teine metabolically labeled SDS extracts of FCR3S1.2
pRBCs with rabbit serum anti-rif–predicted peptide.
Figure 5. Trypsin sensitivity of rifins and binding phenotypes. 125I-labeled
pRBCs containing FCR3S1 parasites at the trophozoite stage were digested
for 10 min at 378C at the indicated concentrations of enzyme. The Triton
X-100–insoluble fraction was analyzed by SDS-PAGE in a 7.5–17.5%
gradient acrylamide gel. Treated cells were washed in PBS, resuspended
in culture medium supplemented with 10% AB1 serum, and either mixed
with uninfected RBCs of the blood group O at a final hematocrit of 5%
and allowed to reform rosettes for 45 min or assayed for cytoadherence
on monolayers of PECAM1/CD31-transfected L cells or CHO cells
transfected with the CD36 receptor, as described in Materials and Meth-
ods. Results represent the mean of three experiments.1399 Fernandez et al.
experienced individuals living in different geographical re-
gions of Africa (Kenya, Liberia, and The Gambia) in assays
of immunoprecipitation and agglutination of FCR3S1.2
and TM284 parasites (Fig. 6 B). Most of the sera immuno-
precipitated one or more radioiodinated rifin polypeptides
in the range of 31–39 kD, both in FCR3S1.2 and TM284
parasites. Qualitative variation was observed in the anti-
genic pattern recognized by different sera in each parasite, a
result consistent with the extent of the rif gene repertoire
and the switching in expressed rifin types. At the same time,
sharing of epitopes between parasite-specific variant forms
of rifins was suggested by the corresponding reactivities of a
majority of the individual sera to the 36-kD doublet of the
FCR3S1.2 parasite and the 39-kD band of the TM284 strain,
a result anticipated if conservation at the 59 and 39 ends is a
widespread feature of rif products. The major radioiodi-
nated 170-kD polypeptide of TM284 was not immunopre-
cipitated by immune sera. The PfEMP1 polypeptides of the
two parasites studied were recognized by all of the sera ex-
cept 72, 100, and 136 (data not shown). The agglutination
of trophozoite-bearing pRBCs by the immune sera was
generally, but not strictly, correlated with their capacity to
immunoprecipitate the small surface antigens.
To study the relative contribution of surface-exposed
epitopes on rifin and PfEMP1 antigens to the agglutination
reaction, we took advantage of the differential sensitivity
that members of these two protein families display to con-
trolled trypsin proteolysis of intact pRBCs. Rifin polypep-
tides of the clone FCR3S1 (35 and 39 kD) are at least 100-
fold less sensitive to the protease than the radioiodinated
PfEMP1 of this parasite, which is no longer detected after
digestion with 1 mg/ml trypsin. Antibodies in immune sera
agglutinated trophozoite-bearing pRBCs digested with 1,
10, or 100 mg/ml trypsin before incubation with antibody
(Table I), suggesting the presence of epitopes in rifins tar-
geted by surface-reactive, agglutinating antibodies raised
during  P. falciparum infections.
Discussion
In this study, we show that the vast structural and anti-
genic variability created by P. falciparum on the surface of
the host erythrocyte has its molecular basis not only in the
PfEMP1 polypeptides, encoded by the var family of genes,
but also in multiple additional parasite-derived products,
including a prominent group of relatively small antigens
encoded by the rif family of genes. These polypeptides are
clonally variant and may undergo posttranslational modifi-
cations resulting in molecular microheterogeneity, a con-
ceptually new source of antigenic diversity on the pRBC
surface (Fig. 7).
Besides the variant adhesin PfEMP1, several undefined
polypeptides of 20–55 kD have reportedly been detected
on the surfaces of erythrocytes infected with mature stages
of P. falciparum (16, 17). In each case, the detection of these
polypeptides was performed after lactoperoxidase-catalyzed
iodination of intact infected erythrocytes, a procedure used
for the radiolabeling of exofacially exposed proteins on cell
Figure 6. Natural antigenicity and variable immunorecognition of rifins. (A) SDS extracts of surface-labeled FCR3S1.2 pRBCs were immunoprecip-
itated with either human immune sera (nos. 164 and 179) or rabbit antisera specific to the semiconserved DBL1 and the conserved ATS domains of the
var1 PfEMP1 protein of FCR3S1.2 (15). Immunoprecipitation of surface-labeled antigens and assessment of agglutinating capacity by sera from individu-
als living in malaria-endemic areas of Kenya (nos. 39, 11, 80, 118, and 209), The Gambia (nos. 72, 136, and 100), and Liberia (nos. 198, 241, 142, 102,
22, 163, 169, 174, 368, and 119). The complete SDS-PAGE patterns of surface-radiolabeled proteins of parasites FCR3S1.2 and TM284 are shown in
Fig. 2, B and C, respectively.1400 P. falciparum Exports Multiple Antigens to the Host Cell Surface
plasma membranes (25). In our analysis of parasite-derived
molecules exported to the host cell surface, with a focus on
products different from var/PfEMP1, we have studied 23
clinical isolates, laboratory-adapted strains, and lines or clones
selected for binding phenotypes, including rosetting and
adhesion to the CD36 receptor. At least 12 polypeptides,
ranging in size from 20 to 170 kD, were identified by mild
radioiodination of intact trophozoite-bearing erythrocytes.
The most common and prominent of these products, both
in fresh clinical isolates and long-term–cultured parasites,
were detected as a distinct group or cluster of bands in the
range of 30–45 kD. The large family of rif genes and its
purported subfamily stevor, encoding potential transmem-
brane proteins (rifins) with a predicted size of 30–40 kD,
has been recently identified in P. falciparum (24, 26). The rif
genes have a two-exon structure, with the first exon coding
for a predicted signal peptide and the second for polypep-
tides containing an extracellular domain with conserved
cysteine residues and a highly variable region, a transmem-
brane segment, and a short cytoplasmic tail that is highly
conserved. According to preliminary estimations, there may
be 200–500 rif genes in the P. falciparum genome. At least
some of the rif genes are transcribed in blood stages (24).
Our finding that rabbit antibodies raised to the conserved
basic COOH terminus of rifin-deduced amino acid sequences
specifically immunoprecipitate surface- or metabolically
labeled polypeptides of 30–45 kD indicates that these anti-
gens are the products of the presumably most abundant
gene family in P. falciparum.
A salient feature of rifin polypeptides is their variability,
in size as well as in the number of distinct components ex-
pressed in different parasites. The capacity of P. falciparum
to undergo clonal antigenic variation has been established
(27, 28), and the switching in the expression of different var
genes, or their product PfEMP1, is correlated with clonal
changes in surface antigenic determinants of the pRBC (3).
Rifin antigens are clonally variant, as the analysis of clones
and subclones of TM284 and FCR3S1.2 parasites demon-
strate. These variable products, which are partially solubilized
by neutral detergents (e.g., Triton X-100) but require
treatment with 1–2% SDS, conditions that disrupt the host
erythrocyte cytoskeleton for complete dissolution, are trans-
ported to the plasma membrane of the infected RBC and
exposed on the surface according to several criteria. They
are (a) readily and consistently labeled by the lactoperoxi-
dase/Na125I/H2O2 method under conditions that fail to
label hemoglobin and (b) cleaved by trypsin treatment of
intact infected erythrocytes under conditions that do not
cleave any other RBC or malarial proteins, except glyco-
phorin polypeptides and the PfEMP1 antigen.
It is unknown how rif gene expression is regulated. The
clusters with varying numbers of radiolabeled bands detected
in freshly isolated as well as in recently cloned parasites may re-
flect, besides several other possible explanations, (a) the non-
clonal composition of the parasites (29, 30), (b) posttranscrip-
tional processing of the product of a single gene, or (c) the
simultaneous expression of several rif genes. Implicit in this last
alternative would be a partial lack of allelic restrictive processes
(e.g., allelic exclusion) controlling the expression of prod-
ucts from the rif loci. This is in contrast to the “one para-
site–one gene” modality of surface protein expression in
the var/PfEMP1 multigene family (31). The finding of micro-
heterogeneity in the rifins could be explained by the concur-
rent expression of several rif genes encoding polypeptides of
similar molecular mass. Alternatively, superimposed to the
variation created at the pRBC surface by the display of pro-
teins comprising semivariable and hypervariable regions, e.g.,
var/PfEMP1, additional layers of antigenic variation could be
generated in asexual stages of P. falciparum by the addition of
carbohydrates, phosphate groups, or perhaps unusual modifi-
cations of polypeptides targeted to the erythrocyte surface. Ex-
amples of posttranslational modifications modulating the
surface architecture, and likely the survival/virulence of
pathogenic microorganisms, are the glycosylation and glycero-
phosphorylation of antigenically variable pilins in the prokary-
ote Neisseria species (32, 33) or the glycosylation and palmitoy-
lation of the variant surface proteins of the eukaryotic parasite
Giardia species (34). Analysis of the rif gene amino acid se-
quences available to date reveals numerous and relatively con-
served potential sites for O- and N-glycosylation.
Allowing for the limited number of clinical isolates in-
cluded in this study, it is interesting to note that rif gene ex-
pression is detected as prominent bands in each of the wild
Table I. Reactivity of Malaria Immune Sera with Trypsin-sensitive 
and Trypsin-resistant Antigens on the pRBC Surface
Sera
Agglutination* of trypsin-digested pRBCs‡
(mg/ml trypsin)
0 1 10 100
011K 41 41 31 11
022L 11 –––
080K 41 41 ––
118K 11 11 11 –
119L 41 31 ––
142L 21 11 11 11
163L 41 21 21 21
174L 21 11 11 –
241L – – – –
Antigen Amount detected on pRBC surface§
%
PfEMP1 100 0 0 0
39-kD rifin 100 97 71 65
35-kD rifin 100 74 37 15
*Agglutination of trophozoite-containing pRBCs after incubation for
1 h at 37°C with 1:2 dilution of sera from donors from Kenya (nos. 11,
80, and 118) or Liberia (nos. 22, 119, 142, 163, 174, and 241). Aggluti-
nation was graded as described in Materials and Methods.
‡FCR3S1 pRBCs were incubated with enzyme at 37°C for 10 min.
§The amount of radioiodinated antigen was estimated by PhosphorImager-
assisted quantitation of cpm in the corresponding SDS-PAGE bands.1401 Fernandez et al.
parasites examined but absent or faint in some of the strains
or parasite lines that were long-term cultured in the labora-
tory. Chromosomal truncations, resulting in gene deletions
as well as gametocytogenesis and cytoadherence phenotype
losses, commonly occur in P. falciparum propagated mitot-
ically in vitro (35–38). The function(s) of the variant rifin
antigens being unknown, it is likely to be essential for sur-
vival of the parasite confronted with the host’s environ-
ment and defence mechanisms but not indispensable for in
vitro growth. The variant nature of the rifin antigens fur-
ther suggests that presence at the pRBC surface is a com-
pelling need.
Our data do not support a direct role of rif products in
rosetting binding. An accessory function in conjunction
with the rosetting ligand PfEMP1 (14, 15) cannot be, how-
ever, completely disregarded. We have previously shown
that the trypsin sensitivity of other binding phenotypes of
multiadhesive parasites, i.e., binding to blood group A, auto-
agglutination of infected erythrocytes, binding of normal Igs,
and adhesion to the CD36 receptor correlate with the en-
zymatic digestion of PfEMP1 (18). In contrast, here we show
that cytoadherence to the endothelial receptor PECAM1/
CD31 is a phenotype associated with the presence on the
pRBC surface of at least one radioiodinatable polypeptide,
the 35-kD rifin in FCR3S1, but apparently not to the radio-
iodinated domain(s) of the PfEMP1 in this parasite. It remains
a possibility that a trypsin-resistant domain of PfEMP1 con-
tains the CD31 binding specificity. The 35-kD rifin may
have, in conjunction with PfEMP1 or not, either a direct
or an accessory role in the binding of pRBCs to CD31 and
other receptors. Although binding to PECAM1/CD31 is a
feature of only some laboratory-adapted strains (39), the
extent of this binding trait in natural P. falciparum popula-
tions and its relationship to severe forms of malaria remains
to be investigated. The prominent labeling of a 170-kD
polypeptide in some isolates and laboratory strains and its
paucity in nonbinding clones has not escaped our atten-
tion. Its labeling pattern may indicate molecular abundance
at the pRBC surface. In immunoprecipitation and Western
blot assays, this band is neither recognized by antibodies to
the highly conserved COOH-terminal segment of PfEMP1
nor by immune sera that immunoprecipitate PfEMP1 and
components of the 30–45-kD rifin cluster from the same
parasite. It remains to be determined whether the 170-kD
polypeptide is too antigenically diverse to be detected by
heterologous antibodies or is not naturally immunogenic.
Regardless of the function of rifins as well as the origin and
function of the other novel surface-exposed polypeptides
described here, their diversity, stability of expression, and
multiplicity of combinatorial patterns (19 distinct types in
23 different parasites) suggests a potential for use as an iso-
late typing tool, conceivably in assays where the expressed
PfEMP1 variant is simultaneously assessed.
Antigens exposed on the pRBC surface undergo clonal
variation at rates of up to 1–2% per generation (28). The
variant adhesin PfEMP1, which mediates binding of in-
fected erythrocytes to vascular endothelial cells and to un-
infected erythrocytes, plays a major role in this antigenic
variation (3, 27, 31). Adults living in areas of high malaria
endemicity have antibodies in their sera capable of reacting
with antigenic determinants of many P. falciparum isolates
from distinct geographic regions (8, 19). These antibodies
recognize conserved and polymorphic parasite antigens, in-
cluding PfEMP1 (9, 40). Our data indicate that rifin pro-
teins are located on the surface of the pRBC and, more-
over, that these parasite-derived components are antigenic
Figure 7. Antigenic diversity
on the infected erythrocyte sur-
face. Sources of the structural
variation created by P. falciparum
on its host cell can be: (1) the
large variant antigen PfEMP1,
encoded by the gene family var,
with z50 genes per genome; (2)
the small antigens rifins encoded
by the multigene family rif, also
termed  stevor (200–500 genes)
(the location of these products at
knobs is not presently estab-
lished); (3) modifications (not yet
defined) of the translated poly-
peptide resulting in further layers
of molecular microheterogeneity;
or (4) additional parasite antigens
transported to the pRBC surface.1402 P. falciparum Exports Multiple Antigens to the Host Cell Surface
in the course of a P. falciparum infection, eliciting a substan-
tial humoral immune response. Furthermore, we show here
that human immune sera agglutinate infected erythrocytes
under conditions such that most, if not all, PfEMP1 prod-
ucts have been removed from the pRBC surface. The pres-
ence in sera of agglutinating or opsonizing antibodies reac-
tive with the infected erythrocyte surface has been shown
to correlate with protection from lethal disease (8, 41). This
preliminary data opens a new avenue for studies conducive
to the eventual elucidation of targets for immune protec-
tion against P. falciparum malaria. The relative contribution
of the rifins, PfEMP1, and other surface antigens on the
pRBC to the triggering of the antibody response, Ig classes,
and immunity buildup have yet to be determined.
This represents the first report of natural immune re-
sponses to surface molecules of intraerythrocytic P. falci-
parum distinct from PfEMP1. The results indicate that more
than one family of genes encoding variable surface-targeted
proteins, perhaps with additional epigenetic generation of
submolecular variation, accounts for the remarkable diver-
sity generated by the parasite in its host cell.
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